The landscape of dementia diagnosis has evolved dramatically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological advancements signify extraordinary progress in understanding neurodegenerative conditions, th... https://wilhelmr653sdo4.wikitidings.com/user